Comparison of Perioperative, Functional, and Oncologic Outcomes of Open vs. Robot-Assisted Off-Clamp Partial Nephrectomy: A Propensity Scored Match Analysis.


Journal

Sensors (Basel, Switzerland)
ISSN: 1424-8220
Titre abrégé: Sensors (Basel)
Pays: Switzerland
ID NLM: 101204366

Informations de publication

Date de publication:
28 Apr 2024
Historique:
received: 22 03 2024
revised: 15 04 2024
accepted: 25 04 2024
medline: 11 5 2024
pubmed: 11 5 2024
entrez: 11 5 2024
Statut: epublish

Résumé

Off-clamp partial nephrectomy represents one of the latest developments in nephron-sparing surgery, with the goal of preserving renal function and reducing ischemia time. The aim of this study was to evaluate and compare the functional, oncologic, and perioperative outcomes between off-clamp robot-assisted partial nephrectomy (off-C RAPN) and off-clamp open partial nephrectomy (off-C OPN) through a propensity score-matched (PSM) analysis. A 1:1 PSM analysis was used to balance variables potentially affecting postoperative outcomes. To report surgical quality, 1 year trifecta was used. Univariable Cox regression analysis was performed to identify predictors of trifecta achievement. The Kaplan-Meier method was used to compare cancer-specific survival (CSS), overall survival (OS), disease-free survival (DFS), and metastasis-free survival (MFS) probabilities between groups. Overall, 542 patients were included. After PSM analysis, two homogeneous cohorts of 147 patients were obtained. The off-C RAPN cohort experienced shorter length of stay (LoS) (3.4 days vs. 5.4 days;

Identifiants

pubmed: 38732928
pii: s24092822
doi: 10.3390/s24092822
pii:
doi:

Types de publication

Journal Article Comparative Study

Langues

eng

Sous-ensembles de citation

IM

Déclaration de conflit d'intérêts

The authors certify that there are no conflicts of interest with any financial organization regarding the material discussed in the manuscript.

Auteurs

Riccardo Mastroianni (R)

Urology, IRCCS "Regina Elena" National Cancer Institute, 00128 Rome, Italy.

Giuseppe Chiacchio (G)

Urology, IRCCS "Regina Elena" National Cancer Institute, 00128 Rome, Italy.
Urology Division, Azienda Ospedaliero-Universitaria delle Marche, Università Politecnica delle Marche, 60126 Ancona, Italy.

Leonard Perpepaj (L)

Urology Division, Azienda Ospedaliero-Universitaria delle Marche, Università Politecnica delle Marche, 60126 Ancona, Italy.

Gabriele Tuderti (G)

Urology, IRCCS "Regina Elena" National Cancer Institute, 00128 Rome, Italy.

Aldo Brassetti (A)

Urology, IRCCS "Regina Elena" National Cancer Institute, 00128 Rome, Italy.

Umberto Anceschi (U)

Urology, IRCCS "Regina Elena" National Cancer Institute, 00128 Rome, Italy.

Mariaconsiglia Ferriero (M)

Urology, IRCCS "Regina Elena" National Cancer Institute, 00128 Rome, Italy.

Leonardo Misuraca (L)

Urology, IRCCS "Regina Elena" National Cancer Institute, 00128 Rome, Italy.

Simone D'Annunzio (S)

Urology, IRCCS "Regina Elena" National Cancer Institute, 00128 Rome, Italy.

Alfredo Maria Bove (AM)

Urology, IRCCS "Regina Elena" National Cancer Institute, 00128 Rome, Italy.

Salvatore Guaglianone (S)

Urology, IRCCS "Regina Elena" National Cancer Institute, 00128 Rome, Italy.

Rocco Simone Flammia (RS)

Urology, IRCCS "Regina Elena" National Cancer Institute, 00128 Rome, Italy.

Flavia Proietti (F)

Urology, IRCCS "Regina Elena" National Cancer Institute, 00128 Rome, Italy.

Marco Pula (M)

Urology, IRCCS "Regina Elena" National Cancer Institute, 00128 Rome, Italy.

Giulio Milanese (G)

Urology Division, Azienda Ospedaliero-Universitaria delle Marche, Università Politecnica delle Marche, 60126 Ancona, Italy.

Costantino Leonardo (C)

Urology, IRCCS "Regina Elena" National Cancer Institute, 00128 Rome, Italy.

Andrea Benedetto Galosi (AB)

Urology Division, Azienda Ospedaliero-Universitaria delle Marche, Università Politecnica delle Marche, 60126 Ancona, Italy.

Giuseppe Simone (G)

Urology, IRCCS "Regina Elena" National Cancer Institute, 00128 Rome, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH